Literature DB >> 27079914

Ovarian-Sparing Surgery in Pediatric Benign Ovarian Tumors.

Paulette I Abbas1, Jennifer E Dietrich2, Jessica A Francis2, Mary L Brandt1, Darrell L Cass1, Monica E Lopez3.   

Abstract

STUDY
OBJECTIVE: To evaluate outcomes of children after ovarian-sparing surgery (OSS) for non-neoplastic and benign neoplastic ovarian lesions.
DESIGN: Retrospective cohort study from January 2003 to January 2012.
SETTING: Single, high-volume, tertiary care hospital. PARTICIPANTS: Children 18 years of age and younger.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Postoperative complications and tumor recurrence after OSS.
RESULTS: One hundred nine patients underwent OSS with a median age of 13.3 years (interquartile range [IQR], 11.4-15.1 years). Eighty-two patients were treated laparoscopically with 4 conversions to an open procedure. Postoperative complications included surgical site infections in 7 patients (6%). Pathology most commonly revealed functional ovarian cysts (n = 57) and mature teratomas (n = 37). Ninety-four patients (86%) were followed for a median of 10.4 months (IQR, 0.72-30.8 months). Fifty-five patients (60%) had subsequent imaging surveillance a median of 7.6 months postoperatively (IQR, 3.9-13 months). Ten patients (10%) developed a second ipsilateral lesion within a median time of 11 months (IQR, 7.7-24 months), of whom 5 girls had repeated surgery for mass enlargement or persistent abdominal pain at a median time of 10.5 months (IQR, 8.0-12.65 months). Fifty-eight patients (63%) began or resumed menses at their most recent follow-up. Three girls became pregnant after OSS at a median follow-up of 5 years (range, 2.4-6.7 years).
CONCLUSION: Benign ovarian lesions in children can be treated successfully with OSS with low recurrence and repeat surgery rates.
Copyright © 2016 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent gynecology; Fertility; Ovarian-sparing surgery; Pediatric ovarian tumors; Pediatric surgery

Mesh:

Year:  2016        PMID: 27079914     DOI: 10.1016/j.jpag.2016.03.009

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  5 in total

1.  The Influence of Living in Rural Areas on the Evolution and Management of Pediatric Ovarian Cystic Lesions: A Retrospective Study on a Cohort from South Eastern Romania.

Authors:  Ioana Anca Stefanopol; Magdalena Miulescu; Luiza Nechita; Ciprian Adrian Dinu; Carmen Bobeica; Alexandru Nechifor; Liliana Baroiu; Sergiu Chirila; Lucreţia Anghel; Victorita Stefanescu; Alin Laurenţiu Tatu
Journal:  Int J Gen Med       Date:  2022-05-27

2.  Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms.

Authors:  Amy E Lawrence; Mary E Fallat; Geri Hewitt; Paige Hertweck; Amanda Onwuka; Amin Afrazi; Christina Bence; Robert C Burns; Kristine S Corkum; Patrick A Dillon; Peter F Ehrlich; Jason D Fraser; Dani O Gonzalez; Julia E Grabowski; Rashmi Kabre; Dave R Lal; Matthew P Landman; Charles M Leys; Grace Z Mak; R Elliott Overman; Brooks L Rademacher; Manish T Raiji; Thomas T Sato; Madeline Scannell; Joseph A Sujka; Tiffany Wright; Peter C Minneci; Katherine J Deans; Jennifer H Aldrink
Journal:  J Pediatr Surg       Date:  2019-10-25       Impact factor: 2.545

3.  Evaluation of the usefulness of laparoscopy in the diagnosis and treatment of adnexal pathologies in the pediatric population.

Authors:  Aleksandra Raźnikiewicz; Wojciech Korlacki; Andrzej Grabowski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-03-28       Impact factor: 1.195

4.  Pediatric whole body MRI detects causative ovarian teratoma in opsoclonus myoclonus syndrome.

Authors:  Christian Park; Imad Aljabban; Julie C Fanburg-Smith; Christa Grant; Michael Moore
Journal:  Radiol Case Rep       Date:  2019-12-19

5.  Ultrasonographic diagnosis and surgical outcomes of adnexal masses in children and adolescents.

Authors:  Gun Gu Kang; Kyeong A So; Ji Young Hwang; Nae Ri Kim; Eun Jung Yang; Seung Hyuk Shim; Sun Joo Lee; Tae Jin Kim
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.